Shenzhen Capital Group

Shenzhen Capital Group Co., Ltd (SCGC) is a venture capital firm founded in 1999 by the Shenzhen Government. The company is dedicated to fostering national industries, developing national brands, and promoting economic transformation through investments in emerging sectors. SCGC primarily targets small to medium enterprises and innovative high-tech companies, focusing on those in various stages of growth, including startups and those undergoing transformation. Its investment portfolio spans industries that align with national policy support, such as information technology, internet services, new media, biopharmaceuticals, new energy, environmental protection, chemical engineering, and high-end equipment manufacturing. With a registered capital of 5.42 billion RMB and significant assets under management, SCGC has established itself as a leader in the venture capital landscape, having invested in numerous companies, many of which have achieved public listings across global capital markets.

Fang Aihua

Investment Director

Haitao Jin

Chairman

Zhou Songgan

Investment Manager

Lin Yunyu

Investment Director

Past deals in Growth Stage

JuCi Technology

Series C in 2025
Juci Technology focuses on the development and production of aluminum nitride powder and ceramic products. The company offers a range of high-grade materials, including high-purity micro-fine aluminum nitride powder and spherical aluminum nitride particles. Additionally, it specializes in complex precision aluminum nitride ceramic products produced through injection molding. Juci Technology has gained significant recognition for its high-quality offerings both domestically and internationally.

OmniSun Information Materials

Series B in 2025
OmniSun Information Materials is a manufacturing company that focuses on the production and sale of high-precision photomask substrate materials. It is a subsidiary of Hunan Electronic Information Industry Group.

Tianjin Nankai Hecheng Technology

Series B in 2024
Tianjin Nankai Hecheng Technology Co. is a biotechnology company that provides resin products.

Xvisio Technology

Series B in 2024
Xvisio Technology is a Shanghai-based company that specializes in designing and developing virtual reality and augmented reality products. The firm focuses on visual simultaneous localization and mapping (VSLAM) technologies, providing solutions for spatial perception and interaction in various applications. Its product offerings include the SeerSense sensor hub, which features low latency 6DOF tracking, depth sensing, and AI capabilities for robotics and automated guided vehicle navigation, as well as the SeerLens AR glasses, which are lightweight and equipped with built-in 6DOF tracking. Xvisio Technology serves a range of industries, including robotics, drones, logistics, gaming, manufacturing, and automotive, and has an additional office in Milpitas, California. The company's innovations enable advanced mapping, 3D environmental reconstruction, and object recognition, positioning it as a key player in the XR technology landscape.

Wingtech Pharmaceutical

Series B in 2024
Wingtech Pharmaceuticals is an innovative pharmaceutical company that develop drugs for the treatment of chronic metabolic diseases.

Shanghai Lixin

Series B in 2024
Lixin specializes in the research and development of full-process tools for the industry.

Laser Link

Series B in 2024
Laser Link is a company specializing in laser communication technologies, focusing on the development of precision optical-mechanical products for various applications. Its innovations encompass inter-satellite communication systems, including co-orbit and off-orbit laser communication terminals and components. Additionally, Laser Link produces precision optical-mechanical payload machines designed for use in spaceborne, airborne, and ground communication environments. By offering advanced products and components, the company aims to enhance communication capabilities across satellite and aircraft platforms.

Yantai Lannacheng Biotechnology

Series B in 2024
Yantai Lannacheng Biotechnology is a biotech business that focuses on the building class I diagnosis and therapy integrated novel tumor nuclear medication research and development platform.and therapy integrated novel tumor nuclear medication research and development platform.

QH Quartz

Series C in 2024
QH Quartz is a manufacturer specializing in high-quality quartz materials for the semiconductor, photovoltaic, and optical fiber industries. The company focuses on quartz device processing, utilizing premium raw materials to produce high-purity and high-precision quartz and related devices. By providing advanced quartz materials, QH Quartz caters to the needs of industrial users seeking reliable and efficient components for their applications.

Qina New Materials

Series C in 2024
Qina New Materials is centered on the manufacturing, exploration, and development of premium special metal materials including wire materials, catalysts, high-temperature alloy master alloys, and electrode meshes for hydrogen production.

Mingdu Zhiyun

Series C in 2024
Mingdu Zhiyun, established in 2017 and located in Hangzhou, China, offers comprehensive contract manufacturing services for pharmaceutical companies. The company specializes in full life cycle solutions that encompass research and development, production, warehousing, and logistics. By leveraging advanced information management systems powered by big data and artificial intelligence, Mingdu Zhiyun enhances the efficiency of the R&D process, enabling drug manufacturers to streamline the development, production, and registration of pharmaceutical products.

Edrive Space

Series B in 2024
Edrive Space specializes in developing advanced aerospace propulsion systems aimed at enhancing the aerospace industry, particularly in China. The company focuses on electrothermal micro-propulsion technologies that address the limitations of traditional electric propulsion systems, such as excessive weight, high power requirements, and low thrust. Their products are designed for the efficient orbiting and networking of micro-nano satellites, making them suitable for applications like emergency collision avoidance of space debris and active deorbiting. Edrive Space's solutions cater to the growing demand for low-cost, standardized, and scalable propulsion systems in the commercial satellite sector, positioning the company as a key player in the evolving landscape of satellite technology.

Xunlian Technology

Series B in 2024
Xunlian Technology is a manufacturer of measuring, control, communication, and navigation devices. Xunlian Technology provides measurement and control communication equipment and services for drones, satellites, rockets, and so on. Satellite navigation core electrical equipment.

MAXVAX

Series C in 2024
MAXVAX is focused on the development and commercialization of innovative vaccines, specifically targeting viral diseases such as rotavirus, shingles, and herpes. The company's technology is designed to enhance treatment options within the biotechnology industry, enabling healthcare professionals to offer improved solutions for patients suffering from these infections. By concentrating on effective vaccine development, MAXVAX aims to contribute significantly to the healthcare sector and improve patient outcomes.

Unitree Robotics

Series B in 2024
Unitree Robotics, founded in 2016 and based in Hangzhou, China, specializes in the development of innovative robotic solutions for consumer and industrial markets. The company's diverse portfolio features a range of robots, including quadrupeds like Laikago, a four-legged robodog designed as a research platform for scientists and roboticists. Additionally, Unitree Robotics offers humanoid robots and advanced perception systems, catering to various applications across different sectors.

Aixin Semiconductor Technology

Series B in 2024
Aixin Semiconductor Technology specializes in the research and development, manufacturing, and sales of semiconductor front-end measurement and testing equipment. It has a production plant of more than 1,000 square meters in Shenzhen, including a thousand-level assembly and commissioning clean room, and a hundred-level, and ten-level laboratory clean room.

ATAPEX

Series B in 2024
ATAPEX specializes in ultra-precision metal sheet processing, primarily targeting the production of precision metal masks essential for OLED panel manufacturing. The company offers a range of products including Divide Open Masks for AMOLED displays, Divide Fine Metal Masks, Micro OLED Open Masks for silicon-based OLEDs, and metal support sheets for display terminals. By addressing challenges such as limited product options, inconsistent quality, and lengthy delivery times, ATAPEX aims to enhance the efficiency of the display panel industry. Its commitment to large-scale mass production and high-quality localization positions the company as a key player in providing comprehensive solutions for customers in the OLED panel sector.

Noding Intelligence

Series B in 2023
Noding Intelligence is a pan-semiconductor testing equipment R&D and manufacturing company.

Petlibro

Series B in 2023
Petlibro is a manufacturer of innovative consumer household appliances focused on pet care. The company designs products that promote pet health and convenience, featuring dispensing schedules for pet food and other essential care items. Among its offerings is an electric nail trimmer that allows for accurate and efficient nail grinding, enhancing the grooming experience for pets. By prioritizing functionality and health, Petlibro aims to simplify the daily responsibilities of pet owners while ensuring the well-being of their pets.

Tongyu Automotive

Series B in 2023
TONGYU AUTOMOTIVE specializes in the development of intelligent driving systems and key components for new energy vehicles. The company focuses on advanced research and development of control-by-wire technologies essential for the next generation of vehicle automation. Its product offerings include brake-by-wire systems, steering-by-wire systems, braking energy recovery systems, and advanced driver assistance systems. By addressing the demands of intelligent and electrified vehicles, TONGYU AUTOMOTIVE aims to contribute significantly to the evolving landscape of the autonomous driving industry.

3N Tech

Series B in 2023
3N Tech is a manufacturer specializing in contact lens care products that prioritize eye health. The company utilizes advanced biotechnology, specifically biomedical electrophoresis deproteinization technology, to create a range of innovative solutions for contact lens users. Their product line includes items designed for protein precipitation removal, sterilization, antibacterial treatment, and safe storage of contact lenses. By focusing on these aspects, 3N Tech aims to provide effective safety protection and promote healthy eye care for individuals who wear contact lenses.

Fujian Technology

Series B in 2023
Futan Technology specializes in the research and development of isostatic graphite materials.

Homerun Smart

Series C in 2023
Shenzhen Qianhai Homerun Technology Co., Ltd. specializes in developing smart pet technology aimed at enhancing the lives of pet owners. Founded in 2015 and headquartered in Guangzhou, China, the company creates innovative products such as smart pet feeders, pet fountains, and smart cat toys. Utilizing artificial intelligence, Homerun Technology focuses on designing solutions that cater to the needs of urban pet owners, particularly those who may have busy lifestyles. The company employs a skilled team of researchers from both domestic and international backgrounds to ensure high-quality development of its products. By integrating smart hardware into daily life, Homerun Technology aims to redefine the pet ownership experience and contribute positively to the pet industry.

Blue Ocean Robot

Series B in 2023
Blue Ocean Robot provides intelligent logistics solutions for the whole plant, including AMR (autonomous mobile robot) to dispatching system, three-dimensional warehousing and MES system.

Jiecheng New Energy

Series B in 2023
Jiecheng New Energy provides recycling and procurement of new energy vehicle decommissioned power batteries and lithium battery-related waste materials, storage, transportation, cascade utilization, dismantling and regeneration, metallurgy, refining, and more.

Haiyunan

Series B in 2023
Haiyunan is a service-oriented enterprise, focusing on building a mobile application security brand.

Svision

Series C in 2023
Svision is a healthcare start-up that develops and produces high-end ophthalmic imaging equipment.

Jiangsu Jing Chuang Advanced Electronic Technology

Series B in 2023
Jiangsu Jing Chuang Advanced Electronic Technology specializes in the research and development of semiconductor material cutting equipment.

Lemon Photonics

Series B in 2023
LEMON Photonics Technologies Co. Ltd. is a high-tech company founded by a team of experienced laser professionals and venture capitals. LEMON focuses on research, sales and industrialization of high-end semiconductor electro-optical devices, modules and systems.

Biosun Pharma

Series B in 2023
Biosun Pharma is a biopharmaceutical company that develops innovative drugs aimed at treating tumors, autoimmune diseases, and inflammatory conditions. The company focuses on molecular targeting and the development of antibody-based therapies, striving to deliver advanced treatment options for patients. By concentrating on these critical areas of medicine, Biosun Pharma seeks to contribute significantly to the healthcare landscape through its research and development efforts.

Rosenbot

Series B in 2022
Rosenbot provides medical robot technology and uses technological innovation to promote the reform of medical models. It is committed to creating a new generation of orthopedic surgery robot systems with intelligent fracture reduction functions, it is the first in the world to realize advanced technologies such as intraoperative real-time 3D navigation, assisted fracture reduction operation, automatic operation planning, etc. The intelligent surgical operation of the whole operation process meets the urgent needs of clinical treatment.

KHAT

Series B in 2022
KHAT is a developer and producer of electronically controlled suspension for passenger vehicles.

DTstack

Series C in 2022
Kangaroo Cloud (quasi-unicorn enterprise) owns two digital technology subsidiaries, cloud technology and cloud technology, mainly for retail, finance, government, tourism, internet and other industries, providing digital stacks including DTinsight, data visualization, and data center solutions. Big data and cloud technology products and services, including solutions and cloud MSPs, help companies achieve digital transformation and promote industrial innovation and social progress.

Linli New Energy

Series B in 2022
Linli New Energy is a smart hardware company that develops and manufactures precursors of lithium iron phosphate cathode materials. It was founded in 2016 in Wuhan, Hubei, China.

Chuangxin Microelectronics

Series B in 2022
Chuangxin Microelectronics focuses on the development and sales of high-precision, low-power battery management and high-efficiency, high-density power management chips. The battery management chip covers all product series and application fields, from full protection to secondary protection. They have battery management chips with high precision, low power consumption, and reliability.

Health Gene Technologies

Series C in 2022
Health Gene Technologies provides premium solutions for multiplexed nucleic acid detection. Based on the high-resolution Capillary Electrophoresis (CE) Platform, HGT has independently developed a series of nucleic acid testing products, established a set of matured clinical nucleic acid testing solutions. Health Gene Technologies provides complete testing solutions for forensic DNA samples. It includes reagents and equipment required in the entire laboratory process.

Yugu Technology

Series C in 2022
Yugu Technology specializes in the development of electric vehicle charging stations, particularly for electric bicycles. The company utilizes artificial intelligence and big data applications to offer intelligent charging and swapping solutions. This approach addresses the needs of consumers and electric bicycle operators by ensuring safe charging and facilitating quick power exchanges. Yugu Technology's focus is on enhancing the efficiency and accessibility of electric bicycle infrastructure, contributing to the growing demand for sustainable transportation solutions.

Boston Micro Fabrication

Series C in 2022
Boston Micro Fabrication is a micro-scale 3D printing system manufacturer dedicated to the development of micro-scale 3D printing systems and functional composites. used in microfluidics, medical devices, electronics, and education.

Origin Quantum

Series B in 2022
Origin Quantum is a full-stack quantum computing company based in China, established in 2017. The company specializes in the development and application of quantum computing technologies, including quantum chips, measurement and control systems, and quantum software. It offers a quantum computing cloud service platform that facilitates access to quantum computing resources beyond laboratory settings. Origin Quantum is committed to advancing the engineering and industrialization of quantum computing in China, aiming to accelerate its applications across various sectors, including quantum artificial intelligence.

TargetRx

Series B in 2022
Shenzhen TargetRx, Inc. is a pharmaceutical research and development company based in Shenzhen, China, established in 2014. As a Sino-American joint venture, it focuses on the creation of innovative anti-tumor drugs, specializing in third-generation small molecule targeted therapies for cancer patients. The company is dedicated to addressing challenges such as acquired drug resistance in cancer treatment. Under the leadership of Dr. Yihan Wang, a prominent medical expert with extensive experience in small molecule targeted therapies, Shenzhen TargetRx aims to position itself as a leading platform for targeted drug development. The company engages in the design, screening, evaluation, optimization, and research of original anti-tumor drug candidates, holding independent intellectual property rights to its innovations. With a commitment to improving cancer treatment outcomes, Shenzhen TargetRx strives to transform cancer from a leading cause of mortality into a manageable chronic condition.

Jaguar Microsystems

Series B in 2022
Jaguar Microsystems is a technology company founded by Dr. Sunny Siu in 2020, specializing in cloud computing and data processing solutions for data centers. The company develops data processing unit (DPU) chips that enhance the efficiency of data processing, with a particular emphasis on accelerated Remote Direct Memory Access (RDMA) and RoCE technologies. Jaguar Microsystems targets domestic cloud service providers, telecommunications, and Internet service providers, while also expanding its offerings to meet the demands of the global market.

Huahuixin Group

Series B in 2022
"Huahuixin" was established in 2017. Its core capabilities are the design, development and production of micro-nano structured optical chips and laser chips, which are in the upstream chip manufacturing link of the optoelectronics industry. There are two main business models: on the one hand, relying on high-end optoelectronic chip technology capabilities to provide joint R&D and foundry services for optoelectronic chip design companies; on the other hand, based on the team's technical capabilities in micro-nano structured optical chips and laser chips, Independent research and development, design and large-scale production of optoelectronic products.

Unitree Robotics

Series B in 2022
Unitree Robotics, founded in 2016 and based in Hangzhou, China, specializes in the development of innovative robotic solutions for consumer and industrial markets. The company's diverse portfolio features a range of robots, including quadrupeds like Laikago, a four-legged robodog designed as a research platform for scientists and roboticists. Additionally, Unitree Robotics offers humanoid robots and advanced perception systems, catering to various applications across different sectors.

Fullcryo

Venture Round in 2022
Fullcryo provides solutions for helium extraction from natural gas, hydrogen liquefaction, and liquefied hydrogen storage.

Yihui Information

Series B in 2022
Yihui Information provides technical assistance and integrated hardware and software solutions. They also offer development kits, virtualization, cloud native that includes mission-critical cloud native, microservices architecture, container management services, and more.

Kai Medtech

Series B in 2022
Kai Medtech is a company focused on the development and supply of medical devices aimed at treating cerebrovascular diseases. It operates within the vascular device industry and emphasizes research and development of neurointerventional medical devices. By utilizing a comprehensive research-production-marketing system, Kai Medtech seeks to enhance treatment options for patients suffering from cerebrovascular and neurological conditions. The company is committed to leveraging nerve intervention techniques as a primary approach to improve patient outcomes in this specialized field.

Lingxi AR

Series B in 2022
Lingxi AR specializes in augmented reality (AR) optical display technology, focusing on the development of lightweight AR glasses with an expansive field of view. The company utilizes advanced optical modules that incorporate nano-scale coupling gratings and optical waveguide technology to facilitate high-quality AR 3D imaging, achieving a viewing angle of up to 36 degrees. By leveraging its strong optics technology and processing capabilities, Lingxi AR aims to deliver cost-effective, mass-produced transparent AR lenses that provide full-color imagery. The company's solutions cater to a diverse range of industries, including education, healthcare, security, industrial maintenance, and fire protection, offering essential display technology for various AR applications.

Regend Therapeutics

Series B in 2022
Regend Therapeutics focuses on the human organ regenerative medicine business and is a global leader in this field. Its core product REGEND001 cell preparation has been accepted by the State Food and Drug Administration and is the world's first autologous stem cell product for respiratory diseases. The company is also the first company in China to be registered by the National Health and Health Commission and the Food and Drug Administration, and is allowed to conduct clinical research on stem cells (Registration No.: CMR-20161214-1002). It is also the first batch of key research and development programs of the Ministry of Science and Technology. And companies that transform research topics. At present, the company has passed ISO9001:2008 quality management system certification, and the stem cell preparation has passed the China Metrology Accreditation (CMA), China Conformity Assessment Committee (CNAS) and IAF International Mutual Recognition. All clinical programs of Jimmy Suisheng are strictly in accordance with the regulations of the National Health Care Commission and the Food and Drug Administration, and are registered with the National Trial Global Database of the National Institutes of Health.

Accro Bioscience

Series B in 2022
Accro Bioscience research centers on the molecular mechanism of regulated cell death such as necroptosis, pyroptosis, and ferroptosis.

H-CHIP TECH

Venture Round in 2022
H-CHIP TECH is a high-end optoelectronic process R&D and foundry. It is headquartered in Tianjin, China.

Leyue Health

Series B in 2021
Leyue Health, operated by Leyo Information Technology (Shanghai) Co., Ltd., is an innovative platform that integrates internet technology with medical services to streamline the claims process for commercial health insurance. The company has developed an intelligent settlement system that connects medical institutions directly with insurers, allowing for real-time online claims processing. This advancement significantly reduces the traditional claims settlement time, which can take up to 30 days, thereby addressing common challenges such as complicated reimbursement procedures and claims difficulties faced by merchants. In addition to its core services, Leyue Health offers a mobile application for users to manage appointments, make payments, and access test results, alongside providing Wi-Fi services in hospitals. This comprehensive approach aims to enhance the efficiency and accessibility of the healthcare reimbursement process.

DERA

Series C in 2021
DERA is a technology-oriented product research and development company dedicated to the development of the underlying storage core technology in the computing architecture—semiconductor storage. Based on self-developed core IP and main control chips, DERA keeps up with international technology trends, fully exploiting potential performance under the premise of following mainstream storage protocols, and provides high-quality products comparable to those of Tier1 suppliers.

Jimuyida

Series B in 2021
Shenzhen Jimuyida Technology Co., Ltd., located in Shenzhen, China, specializes in 3D digital technology, offering a range of products and services that include 3D scanners, engineering modeling services, and home improvement design tools. The company employs advanced technologies such as holography, augmented reality (AR), and virtual reality (VR) to provide customized 3D solutions for various sectors, including retail, design, and real estate. Its software facilitates the creation of detailed, rotatable models, enhancing the visualization and presentation of products for customers. Additionally, Jimuyida has established a research and development center in Wuhan to further innovate in the field of 3D technology.

Harmony Cloud

Series C in 2021
Harmony Cloud, operating as Hangzhou HarmonyCloud Technology Co., Ltd., is a cloud computing startup focused on enhancing IT support for traditional enterprises. The company offers an enterprise Container as a Service (CaaS) platform designed for efficient hybrid cloud management, leveraging the Kubernetes framework. Its platform incorporates advanced technologies such as elastic computing, distributed deployment storage, and software-defined networking, along with robust security features like mirror-level security scanning. Additionally, it provides a user-friendly graphical interface for cloud operations and maintenance, enabling customers to manage resources and applications more effectively. This comprehensive approach aims to accelerate application delivery and improve operational efficiency for businesses in the Chinese market.

Aqara

Series C in 2021
Aqara has emerged as a prominent brand in the smart home market, offering a diverse range of smart home appliances and IoT solutions tailored for both consumers and industrial applications. Known for their elegant design and high-quality products, Aqara aims to enhance daily living by simplifying routine tasks through innovative technology. The company's offerings leverage AI and data analysis, allowing customization to meet individual lifestyle requirements. With a strong emphasis on cost efficiency, Aqara consistently attracts consumers seeking reliable and stylish smart home solutions.

Leads Biolabs

Series C in 2021
Leads Biolabs is a biotechnology company focused on developing innovative antibody-based therapeutics to address unmet medical needs in oncology and immunological diseases. Founded in 2014 and headquartered in China, the company has established a strong research and development pipeline featuring over ten projects centered on monoclonal and bispecific antibodies for cancer immunotherapy. By concentrating on tumor immunotherapy, Leads Biolabs aims to enhance treatment outcomes and access for patients globally, thereby improving their medical conditions and overall quality of life.

SJ Semi

Series C in 2021
SJ Semi is a MEOL foundry focused on front-end wafer manufacturing and quality systems. The company specializes in bumping, Cu pillar, RDL, and testing services for 12" wafers while investing in R&D for fan-out, TSV, interposer, and 3D technologies. With over a decade of experience, SJ Semi aims to support advancements in the semiconductor market.

Veiglo

Series C in 2021
Veiglo specializes in the development and production of solid-state storage devices and chips, catering to various industries such as automotive, maritime, aviation, and aerospace. The company offers a comprehensive range of products, including BGA SATA, BGA NVMe, eMMC, and enterprise SSDs, alongside additional solutions like mini cards and solid-state memory cards. With a strong emphasis on research and development, Veiglo focuses on delivering high-performance, reliable storage solutions that integrate seamlessly with data intelligence and computing applications. Their commitment to quality and innovation positions them as a key player in the solid-state drive market.

Zhiduoji Microelectronics

Series C in 2021
Zhiduoji Microelectronics focuses on the research and development of programmable logic circuit device technology. Established in 2012, it is headquartered in Xi'an, and has an EDA software research center in Beijing.

ZDNS

Series B in 2021
ZDNS is engaged in the technical research and innovation of the internet domain name service system and the IP address service system. Their solutions include education, finance, large-scale enterprise, and the internet.

Jiepei.com

Series B in 2021
Jiepei.com Inc. is an online marketplace based in Hangzhou, China, specializing in the manufacturing of printed circuit boards (PCBs) and related electronic components. The company operates Jieji Extreme Speed PCB Super Factory, which aims to create a collaborative platform for the electronic information industry. Jiepei.com focuses on various sectors including consumer electronics, communications equipment, industrial control, instrumentation, intelligent hardware, and the Internet of Things. It offers professional one-stop services such as PCB customization, surface mount technology (SMT), and component distribution, catering to manufacturers in the electronics field.

SVOLT

Series B in 2021
SVOLT manufacturer of electric batteries. They specialize in the manufacturing of automotive power batteries and energy storage systems. Their market applications include passenger cars, commercial vehicles, energy storage, and light power solutions. Their products include batteries and energy storage batterie. They provide users with energy vehicle charging piles, batteries recycling, and solutions.

IPLUSMOBOT

Series B in 2021
IPLUSMOBOT is one of the global leading companies in the autonomous mobile robot field, ranking the first of China industrial logistics natural navigation AMR market occupancy. IPLUSMOBOT was founded in 2016, whose headquarter is in Hangzhou and its subcompany have been established in Shenzhen and Tokyo. It provides logistics automatic, digital and intelligentized products to manufacturing industry, and helps enterprises increase the configuration efficiency of production and circulation resources, and integrated operation efficiency and benefits. So far, IPLUSMOBOT has served over 1000 customers, and the business scenes cover such industries as semiconductor, FPD, electronics, Lithium battery, photovoltaic, automobile, aviation, household electrical appliances, pharmaceutical, energy, food industry and so on.

Yunphant Blockchain

Series B in 2021
Yunphant Blockchain is a China-based company that specializes in designing and developing blockchain platforms. Founded in 2014, it offers a range of services and products aimed at enhancing the financial industry. The company's backend as a service (BaaS) platform supports applications such as equity and bond trading, notary certification, data security, and supply chain finance. Its offerings include a Blockchain service platform and a Blockchain monitor platform, which provide real-time monitoring of node performance, block generation times, and system exceptions. Additionally, Yunphant Blockchain features a hierarchy ledger, segregated business logic, consortium blockchain capabilities, a YBFT consensus algorithm, and various encryption methods. The company's focus on performance, security, privacy, and scalability allows clients to effectively utilize blockchain technology across multiple sectors.

Bioheng

Series B in 2021
BioHeng is a clinical biopharmaceutical and biotechnology Company focuses on novel immunotherapy and next-generation gene therapy development for treating cancers and various diseases. Founded in 2017, Bioheng has established a high standard GMP grade clinical translational center, and is leading in the field of cell engineering, proliferation and clinical applications. Particularly, Bioheng owns several cutting-edge patents plus extensive industry experience, and has built a complete, closed and automated production system in compliance with regulatory guidelines. In 2018, Bioheng has successfully raised tens of millions of RMB seeding fund from Simcere Pharmaceutical Group, aiming to accelerate the development of immunotherapy via integrating resources from both parties. Bioheng is dedicated to develop safer, effective and less expensive cell therapy drugs to benefit more patients.

Longcheer

Series B in 2021
Longcheer is a company based in Shanghai, China, that specializes in providing design and research solutions for mobile telecommunications devices. It focuses on the development, manufacturing, and servicing of various terminals, including smartphones, tablets, AI PCs, and automotive electronics. In addition to its core activities, Longcheer also offers hardware, software, system testing, and exterior design services. The company is involved in the manufacturing and trading of mobile handsets, printed circuit boards, and related data products. Furthermore, Longcheer engages in property investment activities, diversifying its business portfolio. Founded in 2002, the company has established itself as a key player in the telecommunications sector.

Cryofocus Biotech

Series B in 2021
Cryofocus Biotech is a Shanghai-based cryoablation device manufacturer, focusing on the application of cryogenic technology in the field of cardiovascular interventional therapy.

HappyCast

Series B in 2021
HappyCast develops multi-screen interactive software. Its product can connect smart phone with TV set or projector to display mobile games, live video streaming, video calls and other mobile contents on larger screen.

Laekna Therapeutics

Series C in 2020
Laekna Therapeutics is a clinical-stage biotechnology company focused on drug discovery and development, primarily targeting significant unmet medical needs in oncology and liver diseases. The company has built a robust research and development infrastructure to facilitate the transition of therapeutic molecules from discovery through to registrational trials. Laekna is currently conducting six clinical trials, including three multi-regional trials aimed at addressing treatment-resistant cancers. Its two Core Products, LAE002, an ATP-competitive AKT inhibitor for ovarian cancer, and LAE001, are central to its therapeutic strategy, supported by an additional 14 pipeline candidates. By prioritizing innovative solutions, Laekna Therapeutics aims to enhance treatment options for patients facing challenging medical conditions.

LP Pharmaceuticals

Series C in 2020
LP Pharmaceuticals (Xiamen) Co., Ltd., located in Xiamen Biomedical Industry Base which formulates and manufactures pharmaceuticals with enhanced delivery properties. The company was founded in 2012 by a group of scientists and business professionals with extensive experience in the US and Chinese pharmaceutical industry. Proprietary delivery platforms include mucosal and oral controlled release. Therapeutic areas currently concern central nervous system, digestive system, cardiovascular, cancer and AIDS.

ZStack

Series B in 2020
ZStack is a provider of cloud computing services focused on making cloud technology more accessible for enterprises across various industries, including government, finance, education, and manufacturing. The company offers a range of solutions, including private and hybrid cloud systems, mini hyper-converged machines, and a cloud management platform. Additionally, ZStack provides enterprise-class distributed storage and other cloud-related products, enabling businesses to manage their data center resources—covering computing, networking, and storage—under a unified framework. With a client base of over 2,500 enterprise users, ZStack has also formed partnerships with more than 250 cloud vendors to enhance its ecosystem and channel offerings.

Wenge Group

Series C in 2020
Zhongke Wenge is positioned in the wisdom media big data application, aiming to provide technology engine for China's media transformation and upgrading, and to serve media communication capacity building. The company is facing the influence of China's media, government and enterprises, and is committed to the research and development of new media big data technology and systems. It has formed the "Wenhai" new media big data platform, "Wen Ge" central kitchen, "Wen Si" decision-making service. The platform's three major product systems, as well as the “Wenhai” new media data service platform, the “cloud trace” communication monitoring and evaluation system, the “Yunyong” media visualization analysis system, the “Yayi” text semantic analysis component, and the four flagship products.

Jinfang Pharmaceutical

Series B in 2020
Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies.

Naixuecha

Series B in 2020
Chennai snow tea is well-known tea brand, was founded in 2015 and headquartered in Shenzhen City, Guangdong Province, part of Shenzhen Goods Road Restaurant Management Limited . Innovate to create a "tea + soft European package" form, with young women aged 20-35 as the main customer group, insist on changing the tea base every 4 hours, and the soft European package does not stay overnight. Naixue's tea insists on providing modern people with a good life experience of "a cup of good tea and a soft oval", and hopes to become a promoter of Chinese tea to the world. In December 2017, Nai Xue's tea started to go out of Guangdong area, expand to the whole country, and officially opened the "National Urban Development Plan". As of February 2020, Nei Xue's tea has been distributed in more than 50 cities across the country, with a total of 349 stores. All stores are directly operated and do not join in any form. In March 2018, Nei Xue completed the A+ round of investment, with a valuation of 6 billion yuan, becoming the first unicorn in the tea industry in public information.

RadRock Tech

Series C in 2020
RadRock Tech Co. Ltd, founded in Xiamen in early 2017, is an innovative company specializing in radio frequency integrated circuit (RFIC) design and technology. The company focuses on high-performance power amplifiers and RFIC modules, which are essential for advanced applications in smart mobility, including smartphones, NB-IoT, and the Internet of Cars. RadRock's product offerings consist of front-end power amplifiers, RF antenna tuner modules, and front-end RFIC modules. By developing cutting-edge RFIC solutions, RadRock Tech contributes to the domestic advancements in 4G, 5G, and Internet of Things (IoT) technologies, positioning itself as a key player in the wireless communication sector.

Shiji kaiyuan

Series C in 2020
Shiji kaiyuan provides internet and printing services.

Igenesis

Series C in 2020
Igenesis is a manufacturer of molecular diagnostic technology and products. They focus on real-time molecular diagnostic technology and have developed a series of automated detectors, reagents, reagent smart boxes, and supporting equipment for microbial detection, personalized drug genetic testing, cancer detection, forensic evidence, food safety, and other fields.

Encootech

Series B in 2020
Established in July 2017, Shanghai Yunsheng Information Technology Co., Ltd. is the first high-tech company in China to focus on the development of intelligent RPA software robot platform. Headquartered in Jing'an District, Shanghai, it has a research and development center in Suzhou. In 2019, a subsidiary was opened in Tokyo to arrange the Japanese market. The core team of the company, led by technical experts from Microsoft's cloud computing department, independently developed the first intelligent RPA robot platform in China, Digi4th. Yunsheng Technology focuses on providing intelligent software robot products and solutions for the Internet, finance, energy, telecommunications, manufacturing and other industries. It can enhance the efficiency of traditional industry operations and accelerate digital transformation through RPA empowerment.

GenFleet Therapeutics

Series B in 2020
GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize the body's own immune system.

Maijing Gene

Series B in 2020
Maijing Gene is a gene detection technology company that specializes in R&D, production, and sales of molecular diagnostic products. It is also committed to promoting the application of second-generation high-throughput sequencing technology in the field of precision medicine. Maijing Gene was established in 2015 and is based in Guangzhou, China.

Tikin Media

Series B in 2019
Tikin Media is an innovative advertising company that specializes in elevator marketing solutions, connecting property owners with advertisers. The company installs advanced commercial projectors in elevators, creating a unique advertising platform that enhances consumer exposure to brands. Tikin Media has attracted significant investment from major players in the industry, including Baidu Venture Capital, Sequoia China, and IDG. With a focus on high-end commercial building media operations, Tikin Media has developed proprietary elevator projection technology that transforms traditional advertising methods, enabling mobile interconnectivity and incorporating programmatic ordering and big data analysis capabilities.

Golden Technology

Series B in 2019
Golden Technology is a big data service company based in China that specializes in electronic invoicing solutions powered by blockchain technology. The company has developed a digital invoicing and transaction record-keeping platform that serves various sectors, including grocery retailers, parking lots, and restaurants. This platform offers a range of services, including electronic invoicing, reimbursement processing, record-keeping, and transaction management. By utilizing this technology, Golden Technology provides convenient and cost-effective alternatives to traditional paper-based receipts, streamlining financial processes for businesses and enhancing efficiency in transaction management.

Fapiaoer

Series B in 2019
Fapiaoer is a Chinese electronic invoicing service provider under Tencent-backed Chinese project incubator and group-buying platform GaoPeng. Based on a variety of business success stories, with a strong operating, technical, product team, Gao Peng internal restructuring team to provide electronic invoicing services in an effort to create the most convenient and most reasonable electronic invoice preparation, preservation, and reimbursement experience for users. , Tencent and U.S. GROUPON Each group invested 50 million U.S. dollars to develop a group purchasing business company to become: Wechat commercialization project incubation platform, Tencent eco-layout early investment platform, Group purchasing model integration optimization of new e-commerce platform and other three business lines go hand in hand with diversified technology The company, currently Tencent, is the single largest shareholder of Gao Peng.

Hrain Biotechnology

Series B in 2019
Hrain Biotechnology is a tumor immunotherapy technology developer, using the tumor immunotherapy technology CAR-T to provide cancer patients with precise treatment based on biological and cellular technology, and built centers in Beijing, Jiangsu, Chongqing, Henan and other places. Clinical trial platform.

Baiwang Cloud

Series B in 2019
Baiwang Co., Ltd. provides intelligent solutions and invoice cloud ecological services integrating tax control equipment, invoice management system, electronic invoice service platform, invoice supply chain coordination and invoice financial services.

Fubei Pet

Series B in 2019
Fubei Pet Food is a pet food provider dedicated to providing healthy, safe and high-end pet food and system feeding solutions for pets around the world.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.